Article info
PDFReview Article
Novel therapeutics: response and resistance in ovarian cancer
- Correspondence to Dr Dmitriy Zamarin, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; zamarind{at}mskcc.org
Citation
Novel therapeutics: response and resistance in ovarian cancer
Publication history
- Received April 5, 2019
- Accepted May 16, 2019
- First published August 28, 2019.
Online issue publication
August 28, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2019. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, an indication of whether changes were made, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.